Travere Therapeutics to Report Third Quarter 2022 Financial Results
Travere Therapeutics (NASDAQ: TVTX) will report its third quarter 2022 financial results on October 27, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Travere Therapeutics (NASDAQ: TVTX) will report its third quarter 2022 financial results on October 27, 2022, after market close. A conference call and webcast will follow at 4:30 p.m. ET to discuss the results and provide a general business update. Investors can access the call via dial-in numbers or through a live webcast on the company's website, with a replay available post-event. Travere focuses on developing treatments for patients with rare diseases, aiming to address urgent treatment needs through collaboration with the rare disease community.
Details
News Market Reaction – TVTX
The recorded move for TVTX in the trading session of this news was +0.81%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2022 financial results on Thursday, October 27, 2022, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
Conference Call Information
| Date: | Thursday, October 27, 2022 |
| Time: | 4:30 p.m. ET |
| Dial-in numbers: | +1 (888) 394-8218 (U.S.) or +1 (323) 794-2551 (International) |
| Confirmation code: | 3327353 |
| Live webcast: | Travere.com in the “Events & Presentations” section of the “Investors” page |
A replay of the webcast will be available approximately two hours after the live event and remain archived for approximately 90 days on the Company’s website.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com
Contact:
Investor Relations
888-969-7879
IR@travere.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.